Yi Wang

12PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 17, 2026
ORC6 Exerts Oncogenic Functions in Kidney Renal Clear Cell Carcinoma by Regulating Cell Proliferation and Apoptosis: A Prognostic and Immunological Indicator for Future Clinical Interventions.

|Mar 16, 2026
Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic Mechanisms.

Yi Wang, Yu Song, Hao Ji

|Jul 23, 2025
The Negative Feedback of the Glutamine/Prostatitis Loop Identified Among 1400 Metabolites and Prostatitis via Mendelian Randomization.

Yi Wang, Hao Ji, Yingfei Chen

|May 31, 2024
Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD).

Shiwei Liu, Yang Yu, Jie Xu

|Sep 12, 2023
USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.

Yaoyu Yu, Guihua Chen, Chao Jiang

|Jul 10, 2023
Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC.

Yi Wang, Xinyu Zhang, Guihua Chen

Pageof 2

Frequent Collaborators

2 joint publications

Qianwei Xing

2 joint publications

Hao Ji

2 joint publications

Bingye Zhu

1 joint publications

Chengjian Ji